Chee Goh

5.0k total citations
20 papers, 894 citations indexed

About

Chee Goh is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Chee Goh has authored 20 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Chee Goh's work include Prostate Cancer Treatment and Research (11 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Genetic Associations and Epidemiology (5 papers). Chee Goh is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Genetic Associations and Epidemiology (5 papers). Chee Goh collaborates with scholars based in United Kingdom, United States and Spain. Chee Goh's co-authors include Rosalind A. Eeles, Zsofia Kote‐Jarai, Elena Castro, Douglas F. Easton, Michelle Guy, Edward J. Saunders, Daniel Leongamornlert, Tokhir Dadaev, Malgorzata Tymrakiewicz and Rosemary Wilkinson and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Chee Goh

19 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chee Goh United Kingdom	10	586	329	307	296	218	20	894
Tokhir Dadaev United Kingdom	11	510 0.9×	288 0.9×	288 0.9×	279 0.9×	178 0.8×	20	784
Rosemary Wilkinson United Kingdom	10	432 0.7×	280 0.9×	323 1.1×	264 0.9×	182 0.8×	15	823
Malgorzata Tymrakiewicz United Kingdom	5	386 0.7×	231 0.7×	224 0.7×	224 0.8×	139 0.6×	9	599
Rajesh Kaldate United States	11	251 0.4×	440 1.3×	317 1.0×	406 1.4×	398 1.8×	27	1.1k
Koveela Govindasami United Kingdom	9	318 0.5×	175 0.5×	178 0.6×	158 0.5×	110 0.5×	14	484
Bastien Nguyen United States	13	446 0.8×	116 0.4×	214 0.7×	454 1.5×	384 1.8×	24	870
Susan Brandzel United States	10	361 0.6×	217 0.7×	143 0.5×	196 0.7×	101 0.5×	17	636
Gary Unzeitig United States	12	163 0.3×	248 0.8×	165 0.5×	542 1.8×	524 2.4×	28	855
S. Jezdic Italy	9	233 0.4×	91 0.3×	144 0.5×	316 1.1×	319 1.5×	15	795
Linda Robinson United States	10	106 0.2×	307 0.9×	142 0.5×	185 0.6×	198 0.9×	18	592

Countries citing papers authored by Chee Goh

Since Specialization

Citations

This map shows the geographic impact of Chee Goh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chee Goh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chee Goh more than expected).

Fields of papers citing papers by Chee Goh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chee Goh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chee Goh. The network helps show where Chee Goh may publish in the future.

Co-authorship network of co-authors of Chee Goh

This figure shows the co-authorship network connecting the top 25 collaborators of Chee Goh. A scholar is included among the top collaborators of Chee Goh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chee Goh. Chee Goh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Piasecki, Piotr, Chee Goh, Péter Árkosy, et al.. (2023). A novel abiraterone acetate oral suspension for patients with metastatic prostate cancer: An open-label, phase 3, randomized trial.. Journal of Clinical Oncology. 41(16_suppl). 5052–5052.

Passeron, Thierry, Brigitte Dréno, Susana Puig, et al.. (2023). PD07 Sun exposure and associated risks in 17 countries: UK results. British Journal of Dermatology. 188(Supplement_4). 1 indexed citations

Thurtle, David, Valerie Jenkins, Alexandra L. J. Freeman, et al.. (2021). Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial. European Urology. 80(5). 661–669. 11 indexed citations

Ahmed, Mahbubl, Chee Goh, Edward J. Saunders, et al.. (2019). Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT. Prostate Cancer and Prostatic Diseases. 23(2). 333–342. 9 indexed citations

Castro, Elena, Christos Mikropoulos, Elizabeth Bancroft, et al.. (2016). The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer. The Oncologist. 21(6). 716–722. 26 indexed citations

Goh, Chee & Rosalind A. Eeles. (2014). Germline Genetic Variants Associated with Prostate Cancer and Potential Relevance to Clinical Practice. Recent results in cancer research. 202. 9–26. 7 indexed citations

Leongamornlert, Daniel, Edward J. Saunders, Tokhir Dadaev, et al.. (2014). Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease. British Journal of Cancer. 110(6). 1663–1672. 109 indexed citations

Mikropoulos, Christos, Chee Goh, Daniel Leongamornlert, Zsofia Kote‐Jarai, & Rosalind A. Eeles. (2014). Translating Genetic Risk Factors for Prostate Cancer to the Clinic: 2013 and Beyond. Future Oncology. 10(9). 1679–1694. 5 indexed citations

Mikropoulos, Christos, Elena Castro, Elizabeth Bancroft, et al.. (2014). Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers to detect clinically significant disease: Results from the initial screening round of the IMPACT study.. Journal of Clinical Oncology. 32(4_suppl). 8–8. 1 indexed citations

10.

Eeles, Rosalind A., Chee Goh, Elena Castro, et al.. (2013). The genetic epidemiology of prostate cancer and its clinical implications. Nature Reviews Urology. 11(1). 18–31. 175 indexed citations

11.

Castro, Elena, Chee Goh, & Rosalind A. Eeles. (2013). Prostate Cancer Screening in BRCA and Lynch Syndrome Mutation Carriers. American Society of Clinical Oncology Educational Book. e50–e55. 11 indexed citations

12.

Castro, Elena, Chee Goh, & Rosalind A. Eeles. (2013). Prostate Cancer Screening in BRCA and Lynch Syndrome Mutation Carriers. American Society of Clinical Oncology Educational Book. 33. e50–e55. 11 indexed citations

13.

Castro, Elena, David Olmos, Chee Goh, et al.. (2013). Effect of germ-line BRCA mutations in biochemical relapse and survival after treatment for localized prostate cancer.. Journal of Clinical Oncology. 31(6_suppl). 29–29. 2 indexed citations

14.

Orozco, Gisela, Chee Goh, Ali Amin Al Olama, et al.. (2012). Common genetic variants associated with disease from genome‐wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis. British Journal of Urology. 111(7). 1148–1155. 9 indexed citations

15.

Leongamornlert, Daniel, Nadiya Mahmud, Malgorzata Tymrakiewicz, et al.. (2012). Germline BRCA1 mutations increase prostate cancer risk. British Journal of Cancer. 106(10). 1697–1701. 201 indexed citations

16.

Goh, Chee, Fredrick R. Schumacher, Douglas F. Easton, et al.. (2012). Genetic variants associated with predisposition to prostate cancer and potential clinical implications. Journal of Internal Medicine. 271(4). 353–365. 56 indexed citations

17.

Castro, Elena, David Olmos, Chee Goh, et al.. (2012). BRCA carrier status as an independent prognostic factor associated with earlier biochemical relapse in local prostate cancer.. Journal of Clinical Oncology. 30(15_suppl). 1545–1545. 1 indexed citations

18.

Goh, Chee, Fredrick R. Schumacher, Zsofia Kote‐Jarai, et al.. (2012). Abstract 1650: Overview of the clinical ELLIPSE (ELucidating Loci Involved in Prostate cancer SuscEptibility) Consortium (CEC). Cancer Research. 72(8_Supplement). 1650–1650. 1 indexed citations

19.

Kote‐Jarai, Zsofia, Daniel Leongamornlert, Edward J. Saunders, et al.. (2011). BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. British Journal of Cancer. 105(8). 1230–1234. 256 indexed citations

20.

Castro, Elena, Chee Goh, David Olmos, et al.. (2011). Correlation of germ-line BRCA2 mutations with aggressive prostate cancer and outcome.. Journal of Clinical Oncology. 29(15_suppl). 1517–1517. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact